Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx
Current antiviral therapies help keep HBV under control, but they are not curative, as they are unable to eliminate the intracellular viral replication intermediate termed covalently closed circular DNA (cccDNA). Therefore, there remains an urgent need to develop strategies to cure CHB. Functional s...
Saved in:
Published in | Journal of hepatology Vol. 74; no. 3; pp. 522 - 534 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.03.2021
Elsevier Science Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!